Physician

Vachaspathi Palakodeti, MD

According to 2025 Medicare claims, Vachaspathi Palakodeti, MD (NPI: 1649224387) practices cardiology in the El Centro, CA market, with the plurality of this provider's patient population coming from Imperial, CA. This provider's primary affiliated billing organization is IMPERIAL VALLEY FAMILY CARE MEDICAL GROUP APC (NPI: 1275581894; TIN: 330652678) and primary practice location at 92251-9805. Palakodeti is affiliated with the Aledade 60 CA MSSP Enhanced (ACO ID: A4775), participating under the MSSP model.

Palakodeti's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 3,256 traditional Medicare patients, billed 38,413 HCPCS/CPT codes, and received $2,229,142 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 16,792 prescription claims across 2,526 beneficiaries totaling $3,636,860 in drug costs, led by Eliquis (Apixaban). 2018 DME data shows 22 claims. Open Payments data shows 5 records totaling $383. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $268,750 to $3,636,860. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	4,516	37,614	$1,785,112
2016	4,171	37,620	$1,716,112
2017	4,111	39,283	$1,486,459
2018	3,887	28,491	$1,373,722
2019	3,674	30,447	$1,426,360
2020	3,204	36,134	$1,248,670
2021	3,131	40,249	$1,593,570
2022	3,253	50,798	$1,969,093
2023	3,285	45,901	$2,165,690
2024	3,256	38,413	$2,229,142

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,120	5,265	$268,750
2016	946	4,338	$233,790
2017	1,049	4,414	$326,125
2018	1,212	4,899	$441,420
2019	1,287	4,982	$487,126
2020	1,416	5,889	$758,364
2021	1,840	8,362	$1,293,305
2022	2,259	15,199	$2,826,182
2023	2,390	15,433	$3,472,068
2024	2,526	16,792	$3,636,860

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	22	$1,003
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	1,940	2,041	$132
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,922	3,687	$98
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	914	6,728	$49
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,197	1,462	$6
93005	Routine electrocardiogram (ecg) using at least 12 leads with tracing	1,197	1,462	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	975	52,455	$989,398
Entresto	Sacubitril/Valsartan	1,019	45,710	$969,080
Xarelto	Rivaroxaban	655	35,235	$633,221
Jardiance	Empagliflozin	374	19,740	$358,419
Farxiga	Dapagliflozin Propanediol	135	7,500	$131,967

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$383	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vachaspathi Palakodeti, MD?

Tedicare shows public-source Medicare data for Vachaspathi Palakodeti, MD (NPI 1649224387), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vachaspathi Palakodeti, MD have ACO affiliation data?

Vachaspathi Palakodeti, MD is shown with ACO affiliation data for Aledade 60 CA MSSP Enhanced (MSSP, ACO ID A4775).

What billing organization is linked to Vachaspathi Palakodeti, MD?

Vachaspathi Palakodeti, MD is linked to IMPERIAL VALLEY FAMILY CARE MEDICAL GROUP APC (billing NPI 1275581894) in the available physician profile data.

Does Vachaspathi Palakodeti, MD have Open Payments data?

Vachaspathi Palakodeti, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.